A theme covering deteriorating performance in the wholesale business for prescription drugs and other pharmaceuticals, with net sales and operating profit below the same period of the previous year. Unlike themes concerning the manufacturing and marketing business, the active pharmaceutical ingredients sales business, or the pharmaceutical business as a whole turning loss-making, this theme focuses on the wholesale business segment's performance.